Please login to the form below

Not currently logged in
Email:
Password:

FDA approves HIV antibodies screening test

The FDA has approved the Abbott Prism HIV O Plus assay as a screening tool to detect HIV in blood and organ donations

The US Food and Drug Administration (FDA) has approved the Abbott Prism HIV O Plus assay as a screening tool designed to detect the presence of antibodies to HIV type 1, groups M and O and HIV type 2.

The assay is the second donor screening test licensed for the detection of antibodies to HIV type 1, group O, and is one of five assays that run on the fully automated Abbott Prism System. During the past decade, fourth-generation assays have been developed that combine antigen and antibody detection in a single assay.

The test runs on Abbott Laboratories' Illinois-based system and will be used to screen for HIV in blood and organ donations.

HIV group M is the most common subgroup of the virus in the US and group O occurs primarily in West Africa.

21st September 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
emotive.

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics